Micro RNAs and Circular RNAs in Different Forms of Otitis Media

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2023 Apr 13

PMID 37047725

Authors

Michal Kotowski

Paulina Adamczyk

Jaroslaw Szydlowski

Affiliations

Soon will be listed here.

Abstract

The aim of this comprehensive review was to present the current knowledge on the role of microRNAs (miRNAs) in acute, recurrent, and chronic forms of otitis media. Special attention was focused on cholesteatoma of the middle ear. MicroRNAs modulate gene expression, which, in turn, influences the development and likelihood of the recurrence of acute and aggressive chronic middle ear inflammatory processes. Moreover, this study discusses the modulating role of a specific subgroup of noncoding RNA, circular RNA (circRNA). Recognizing the precise potential pathways and the mechanisms of their function may contribute to a better understanding of the molecular bases of middle ear diseases and identifying novel methods for treating this demanding pathology. Articles published between 2009 and 2022 were used in this analysis. In this review, we provide a complete overview of the latest progress in identifying the role and mechanisms of particular miRNAs and circRNAs in acute, recurrent and chronic forms of otitis media.

References

Sun H, Cai J, Shen S, Ren X . Hypothermia treatment ameliorated cyclin-dependent kinase 5-mediated inflammation in ischemic stroke and improved outcomes in ischemic stroke patients. Clinics (Sao Paulo). 2019; 74:e938. PMC: 6791290. DOI: 10.6061/clinics/2019/e938. View

Starke S, Jost I, Rossbach O, Schneider T, Schreiner S, Hung L . Exon circularization requires canonical splice signals. Cell Rep. 2014; 10(1):103-11. DOI: 10.1016/j.celrep.2014.12.002. View

Cao Q, Wang N, Ren L, Tian J, Yang S, Cheng H . miR-125a-5p post-transcriptionally suppresses GALNT7 to inhibit proliferation and invasion in cervical cancer cells via the EGFR/PI3K/AKT pathway. Cancer Cell Int. 2020; 20:117. PMC: 7147043. DOI: 10.1186/s12935-020-01209-8. View

Li N, Qin Z . Inflammation-induced miR-802 promotes cell proliferation in cholesteatoma. Biotechnol Lett. 2014; 36(9):1753-9. DOI: 10.1007/s10529-014-1545-y. View

Infantino V, Santarsiero A, Convertini P, Todisco S, Iacobazzi V . Cancer Cell Metabolism in Hypoxia: Role of HIF-1 as Key Regulator and Therapeutic Target. Int J Mol Sci. 2021; 22(11). PMC: 8199012. DOI: 10.3390/ijms22115703. View

Yu J, Xiao Z, Zhao R, Lu C, Zhang Y . Paeoniflorin suppressed IL-22 via p38 MAPK pathway and exerts anti-psoriatic effect. Life Sci. 2017; 180:17-22. DOI: 10.1016/j.lfs.2017.04.019. View

Hu Y, Qian X . Hsa_circ_0074491 regulates the malignance of cholesteatoma keratinocytes by modulating the PI3K/Akt pathway by binding to miR-22-3p and miR-125a-5p: An observational study. Medicine (Baltimore). 2021; 100(37):e27122. PMC: 8447995. DOI: 10.1097/MD.0000000000027122. View

Vo D, Karanam N, Ding L, Saha D, Yordy J, Giri U . miR-125a-5p Functions as Tumor Suppressor microRNA And Is a Marker of Locoregional Recurrence And Poor prognosis in Head And Neck Cancer. Neoplasia. 2019; 21(9):849-862. PMC: 6642270. DOI: 10.1016/j.neo.2019.06.004. View

Val S, Krueger A, Poley M, Cohen A, Brown K, Panigrahi A . Nontypeable Haemophilus influenzae lysates increase heterogeneous nuclear ribonucleoprotein secretion and exosome release in human middle-ear epithelial cells. FASEB J. 2017; 32(4):1855-1867. PMC: 5893168. DOI: 10.1096/fj.201700248RR. View

10.

Kuo C, Liao W, Shiao A . A review of current progress in acquired cholesteatoma management. Eur Arch Otorhinolaryngol. 2014; 272(12):3601-9. DOI: 10.1007/s00405-014-3291-0. View

11.

Lei K, Bai H, Wei Z, Xie C, Wang J, Li J . The mechanism and function of circular RNAs in human diseases. Exp Cell Res. 2018; 368(2):147-158. DOI: 10.1016/j.yexcr.2018.05.002. View

12.

Yao L, Zhang W, Zheng J, Lu X, Zhang F . miR-199a Targeting PNRC1 to Promote Keratinocyte Proliferation and Invasion in Cholesteatoma. Biomed Res Int. 2021; 2021:1442093. PMC: 8610695. DOI: 10.1155/2021/1442093. View

13.

Kozomara A, Birgaoanu M, Griffiths-Jones S . miRBase: from microRNA sequences to function. Nucleic Acids Res. 2018; 47(D1):D155-D162. PMC: 6323917. DOI: 10.1093/nar/gky1141. View

14.

Fedele M, Battista S, Kenyon L, Baldassarre G, Fidanza V, Klein-Szanto A . Overexpression of the HMGA2 gene in transgenic mice leads to the onset of pituitary adenomas. Oncogene. 2002; 21(20):3190-8. DOI: 10.1038/sj.onc.1205428. View

15.

Leung A, Wong A . Acute Otitis Media in Children. Recent Pat Inflamm Allergy Drug Discov. 2017; 11(1):32-40. DOI: 10.2174/1874609810666170712145332. View

16.

Friedman R, Farh K, Burge C, Bartel D . Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2008; 19(1):92-105. PMC: 2612969. DOI: 10.1101/gr.082701.108. View

17.

Xie S, Jin L, Yin T, Ren J, Liu W . Microarray analysis and functional prediction of differentially expressed circular RNAs in acquired middle ear cholesteatoma. Biomed Eng Online. 2021; 20(1):129. PMC: 8684697. DOI: 10.1186/s12938-021-00960-x. View

18.

Bouchie A . First microRNA mimic enters clinic. Nat Biotechnol. 2013; 31(7):577. DOI: 10.1038/nbt0713-577. View

19.

Chen G, Gharib T, Huang C, Taylor J, Misek D, Kardia S . Discordant protein and mRNA expression in lung adenocarcinomas. Mol Cell Proteomics. 2002; 1(4):304-13. DOI: 10.1074/mcp.m200008-mcp200. View

20.

Liu D, Ma X . MiR-508-3p promotes proliferation and inhibits apoptosis of middle ear cholesteatoma cells by targeting PTEN/PI3K/AKT pathway. Int J Med Sci. 2021; 18(14):3224-3235. PMC: 8364443. DOI: 10.7150/ijms.60907. View